左心室辅助装置接受者血流感染与结局
该回顾性研究分析了2006至2016年间257例连续流左心室辅助装置(LVAD)成人接受者,发现第一年血流感染发生率为32.1%,血流感染与全因死亡和卒中风险显著增加相关,但与泵血栓或心脏移植概率无关。
要点
- LVAD支持第一年血流感染发生率为32.1%。
- 血流感染与全因死亡风险显著增加相关(HR 5.51)。
- 血流感染与卒中风险显著增加相关(HR 2.41)。
核心结论
- 血流感染在LVAD接受者中常见,且与全因死亡和卒中风险显著增加相关。
研究设计与样本
- 回顾性分析2006至2016年单中心257例连续流LVAD成人接受者。
主要发现
- 第一年血流感染发生率为32.1%(95%CI 26.4-37.9)。
- 血流感染与全因死亡风险增加相关(HR 5.51,95%CI 3.57-8.51,P<0.001)。
- 血流感染与卒中风险增加相关(HR 2.41,95%CI 1.24-4.68,P=0.010)。
- 血流感染与泵血栓风险或心脏移植概率无关联。
- 血流感染的独立危险因素包括术前白蛋白和ECMO/IABP支持。
临床怎么用
- 应重视LVAD接受者血流感染的预防与治疗以改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Our aim was to investigate associations between blood stream infection [≥1 positive blood culture (BC)] and outcomes in recipients of a left ventricular assist device (LVAD). METHODS: We retrospectively analysed all adult recipients of a continuous-flow LVAD between 2006 and 2016 at the Division of Cardiac Surgery, Medical University of Vienna (n = 257; devices: Medtronic HeartWare® HVAD®, Abbott HeartMate II®, Abbott HeartMate 3™). The primary outcome was all-cause mortality during follow-up. Secondary outcomes included the risk of stroke and pump thrombus during follow-up as well as the probability of heart transplantation (HTx). Risk factors for the development of ≥1 positive BC were evaluated additionally. RESULTS: The incidence of ≥1 positive BC during the first year of LVAD support was 32.1% [95% confidence interval (CI) 26.4-37.9]. Multivariable Cox proportional cause-specific hazards regression analysis showed that a positive BC was associated with significantly increased all-cause mortality [hazard ratio (HR) 5.51, 95% CI 3.57-8.51; P < 0.001]. Moreover, a positive BC was associated with a significantly increased risk of stroke (HR 2.41, 95% CI 1.24-4.68; P = 0.010). There was no association with the risk of pump thrombus or the probability of HTx. Independent risk factors for a positive BC included preoperative albumin and extracorporeal membrane oxygenation/intra-aortic balloon pump support. CONCLUSIONS: Blood stream infection is common and associated with a significantly increased risk of all-cause mortality and stroke at any given time during LVAD support. Effective strategies of prevention and treatment are necessary.
引用
- Angleitner P, Matic A, Kaider A, et al. Blood stream infection and outcomes in recipients of a left ventricular assist device. Eur J Cardiothorac Surg. 2020. PMID: 32510152. doi:10.1093/ejcts/ezaa153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。